DM
INDV icon

Deerfield Management’s Indivior Pharmaceuticals INDV Stock Holding History

Deerfield Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.7M Sell
1,648,895
-1,448,895
-47% -$52.6M 0.71% 38
2026
Q1 		$94.4M Sell
3,097,790
-295,273
-9% -$9.75M 1.11% 24
2025
Q4 		$122M Sell
3,393,063
-3,593,748
-51% -$110M 1.55% 18
2025
Q3 		$168M Sell
6,986,811
-3,580,349
-34% -$74.9M 2.57% 7
2025
Q2 		$156M Hold
10,567,160
– – 2.83% 8
2025
Q1 		$101M Buy
10,567,160
+1,684,000
+19% +$17.7M 1.99% 14
2024
Q4 		$110M Buy
8,883,160
+3,790,518
+74% +$39M 2.09% 14
2024
Q3 		$49.7M Buy
+5,092,642
New +$59.6M 0.74% 30

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deerfield Management's INDV Position: Q2 2026 in Review

Deerfield Management reduced its Indivior Pharmaceuticals (INDV) stake by 47% in Q2 2026, selling an estimated $52.6M and leaving 1,648,895 shares worth $67.7M. The position accounts for 0.71% of the portfolio, ranked #38.

Deerfield Management first reported a position in INDV in Q3 2024 and has held it in 8 quarters since. The position peaked at $168M in Q3 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Deerfield Management held 1,648,895 shares of Indivior Pharmaceuticals worth $67.7M as of Q2 2026.
  • Deerfield Management sold 1,448,895 Indivior Pharmaceuticals shares in Q2 2026, an estimated $52.6M.
  • Indivior Pharmaceuticals made up 0.71% of Deerfield Management's portfolio in Q2 2026, its #38 holding.
  • Deerfield Management first reported a position in Indivior Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Deerfield Management's Indivior Pharmaceuticals position peaked at $168M in Q3 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.